Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. | Front Immunol | 2022 | 35911752 | PubTator, text mining | PubMed |
| Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review. | Front Nutr | 2022 | 35911092 | PubTator, text mining | PubMed |
| Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1. | Hum Genomics | 2022 | 35906672 | PubTator, text mining | PubMed |
| Genetic variations in UCA1, a lncRNA functioning as a miRNA sponge, determine endometriosis development and the potential associated infertility via regulating lipogenesis. | PLoS One | 2022 | 35901079 | PubTator, text mining | PubMed |
| Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. | Molecules | 2022 | 35889373 | PubTator, text mining | PubMed |
| Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis. | Biomedicines | 2022 | 35884973 | PubTator, text mining | PubMed |
| Interplay between Lipid Metabolism, Lipid Droplets, and DNA Virus Infections. | Cells | 2022 | 35883666 | PubTator, text mining | PubMed |
| Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction. | Biomolecules | 2022 | 35883525 | PubTator, text mining | PubMed |
| Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons. | Front Cell Dev Biol | 2022 | 35874835 | PubTator, text mining | PubMed |
| A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35873479 | PubTator, text mining | PubMed |
| Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling. | Stem Cell Res Ther | 2022 | 35870954 | PubTator, text mining | PubMed |
| Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35866603 | PubTator, text mining | PubMed |
| Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. | Front Physiol | 2022 | 35860662 | PubTator, text mining | PubMed |
| ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. | Sci Adv | 2022 | 35857506 | PubTator, text mining | PubMed |
| Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy. | J Pediatr Endocrinol Metab | 2022 | 35850931 | PubTator, text mining | PubMed |
| Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions. | Front Bioeng Biotechnol | 2022 | 35845425 | PubTator, text mining | PubMed |
| Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis. | Nat Commun | 2022 | 35840613 | PubTator, text mining | PubMed |
| Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. | Front Immunol | 2022 | 35833121 | PubTator, text mining | PubMed |
| Mechanisms and inhibition of Porcupine-mediated Wnt acylation. | Nature | 2022 | 35831507 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=32